by admin_63069 | Sep 27, 2023 | Related Topics
Patients with prostate cancer may have an inherited or acquired BRCA mutation, and both can have treatment implications.
by admin_63069 | Sep 23, 2023 | Related Topics
The UK REIMAGINE study suggests that MRI screening can not only bolster PSA screening, but also has the potential to be the central component of a national prostate cancer screening program.
by admin_63069 | Sep 22, 2023 | News You Can Use
Ongoing challenges for the treatment of patients with oligometastatic disease
by admin_63069 | Sep 19, 2023 | Related Topics
New study reports benefit of small amounts of daily vigorous physical activity.
by admin_63069 | Sep 18, 2023 | News You Can Use
Approximately half of prostate cancer patients with clinically actionable gene variants do not meet the NCCN guideline criteria for genetic testing, according to findings from the PROCLAIM trial.
